Fleishman S B, Lavin M R, Sattler M, Szarka H
Department of Medicine and Psychiatry, Long Island Jewish Medical Center, New Hyde Park, NY 11042.
Am J Psychiatry. 1994 May;151(5):763-5. doi: 10.1176/ajp.151.5.763.
A structured, prospective telephone interview was used to assess the prevalence of akathisia in 24 cancer patients receiving metoclopramide or prochlorperazine during or after chemotherapy. Half of the patients reported subjective motor restlessness, and 75% stated that they would not have informed staff. This report suggests that akathisia is frequently unrecognized in chemotherapy patients receiving metoclopramide and prochlorperazine.